Two American medical workers active in the Ebola region are brought back for treatment at Emory Medical Center.
Reason enough for comprehensive reporting on the so-far incurable disease. We are all hopeful that it will not spread to other areas, and especially not to our countries.

The Zmap serum being administered to the two being treated in Atlanta is the result of cooperation among a number of agencies, private and public. Companies involved are Mapp, Leaf Bio and Toronto-based Defyrus Inc.

The Public Health Agency of Canada is the Defyrus partner in Canada,
The U. S. Army Medical Research Institute of Infectious Diseases (located in Maryland) is the driver behind much of the work. Other partners in development of treatment and vaccines are in Asia as well as the U. S. and Canada.